Literature DB >> 2413558

[Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo].

A Tasca, M Barulli, A Cavazzana, F Zattoni, W Artibani, F Pagano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2413558

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN： 0393-2249            Impact factor:   3.720


× No keyword cloud information.
  9 in total

1.  A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

Authors:  Fatih Hizli; M Cemil Uygur
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

2.  Randomized double-blind controlled clinical trials with herbal preparations of Serenoa repens fruits in treatment of lower urinary tract symptoms : An overview.

Authors:  Rainer C Görne; Tankred Wegener; Olaf Kelber; Björn Feistel; Jürgen Reichling
Journal:  Wien Med Wochenschr       Date:  2016-11-29

Review 3.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

4.  Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract of Serenoa repens (Permixon) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-beta-sitosterol.

Authors:  G Chevalier; P Benard; H Cousse; T Bengone
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.441

Review 5.  Serenoa repens for benign prostatic hyperplasia.

Authors:  James Tacklind; Roderick Macdonald; Indy Rutks; Judith U Stanke; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 6.  Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.

Authors:  Roderick MacDonald; James W Tacklind; Indulis Rutks; Timothy J Wilt
Journal:  BJU Int       Date:  2012-05-02       Impact factor: 5.588

Review 7.  Serenoa repens (saw palmetto): a systematic review of adverse events.

Authors:  Taofikat B Agbabiaka; Max H Pittler; Barbara Wider; Edzard Ernst
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  Pharmacological effects of saw palmetto extract in the lower urinary tract.

Authors:  Mayumi Suzuki; Yoshihiko Ito; Tomomi Fujino; Masayuki Abe; Keizo Umegaki; Satomi Onoue; Hiroshi Noguchi; Shizuo Yamada
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

Review 9.  Serenoa repens for benign prostatic hyperplasia.

Authors:  James Tacklind; Roderick MacDonald; Indy Rutks; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.